Clinical Trials Cervical Cancer Study
Protocol Title:
ACRIN 6671/GOG 0233: Utility of Pre-Operative PET/CT and USPIO MRI Prior to Primary Chemoradiation Therapy to Detect Retroperitoneal Lymph Node Metastasis in Patients with Loco-regionally Advanced (IB2, IIA=$ CM, IIB-IVA) Carcinoma of the Cervix.
Working Title:
Use of Pre-Operative PET/CT and USPIO MRI to Detect Abdominal Lymph Node Metastasis in Patients with Advanced Carcinoma of the Cervix.Summary:
This is a multicenter clinical trial to define the utility of pre-operative Combidex (iron-based contrast) MRI scanning and FDG-PET/CT scanning prior to chemoradiation to detect retroperitoneal (abdominal) lymph node metastasis in patients with locoregionally advanced cancer of the cervix.Enrollment Status:
Pending IRB approval.Principal Investigator:
Rola Saouaf, MDIRB Approval Number:
PendingMedical Specialty Area:
Magnetic Resonance Imaging, PET/CT Imaging, Gynecologic OncologyCondition/Disease:
Cancer of the cervixIRB Approval Expiration Date:
PendingContact Information for patients wishing more information:
Name: Rene Siegel, Program Coordinator, Imaging Research
Phone: (310) 423-3398
E-mail: SiegelR@cshs.org
